Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Investor Presentation On Q2 FY 2022-23

Investor Presentation on Q2 FY 2022-23
14-11-2022
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Standalone And Consolidated Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2022

standalone and consolidated un-audited Financial Results for the quarter and half year ended 30th September, 2022
12-11-2022
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 12-Nov-2022 To Consider Financial Statements For The Period Ended September 2022

outcome of the Board Meeting held on 12-Nov-2022 to consider financial statements for the period ended September 2022
12-11-2022
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Second Quarter And Half Year Ended 30Th September, 2022.

SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve un-audited Financial Results for the second quarter and half year ended 30th September, 2022.
05-11-2022
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Credit Rating

Credit Rating Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.
03-11-2022
Bigul

SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Acquisition

Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 for Investment in LLP
18-10-2022
Next Page
Close

Let's Open Free Demat Account